Upstream Bio, Inc. UPB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s financing cash flow?
- Upstream Bio, Inc. (UPB) reported financing cash flow of $598K in Q1 2026.
- How has Upstream Bio, Inc.'s financing cash flow changed year-over-year?
- Upstream Bio, Inc.'s financing cash flow increased by 1858.8% year-over-year, from -$34K to $598K.
- What is the long-term trend for Upstream Bio, Inc.'s financing cash flow?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s financing cash flow has grown at a -86.3% compound annual growth rate (CAGR), from $129.55M to $2.44M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.